We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection.
- Authors
Boussen, Inès; Salmona, Maud; Sicre De Fontbrune, Flore; Xhaard, Aliénor; De Castro, Nathalie; Delaugerre, Constance; Chaix, Marie-Laure; Molina, Jean-Michel
- Abstract
We report the case of an allogeneic stem cell transplant recipient with nosocomial acquisition of SARS-CoV-2 infection who received antispike neutralizing monoclonal antibody bamlanivimab 2 days after diagnosis of SARS-CoV-2 infection but progressed to severe COVID-19 pneumonia and died with the selection of E484K/Q resistance mutations to bamlanivimab.
- Publication
Antiviral Therapy, 2024, Vol 29, Issue 1, p1
- ISSN
1359-6535
- Publication type
Article
- DOI
10.1177/13596535221097495